1 The general public guidance is conservative because it covers all GLP-1 medications, including those without breast milk data
Who Are GLP-1 Medications for
HBOT has been shown to be of benefit in Central Retinal Artery Occlusion (CRAO), and it seems logical that HBOT could be helpful in NAION, even though the mechanism of retinal injury is different
Teva Pharmaceuticals Press Release on Generic Saxenda Approval Saxenda review FDA APPROVES WEGOVY (SEMAGLUTIDE) FOR MASH (FATTY LIVER DISEASE) August 2025 Metabolic dysfunctionassociated steatohepatitis (MASH), also known as fatty liver disease, is a condition strongly associated with obesity that causes chronic liver inflammation and scarring
And none of my GPs (3 to date as ive moved around) and my Endocrinologist also doesn't know why
Research increasingly shows that loss of muscle mass and strength has an adverse impact on health, particularly during aging